Cargando…
SAT-571 Restoration of Thyroid Hormone Receptor Beta Signaling Reprograms Anaplastic Thyroid Cancer Cells
Anaplastic thyroid cancer (ATC) is among the most lethal human cancers, with an average survival time of six months. These tumors are characterized by rapid local extension, resistance to radioactive iodine therapy and mainstream chemotherapy, and distant metastasis. There are very limited treatment...
Autores principales: | Gillis, Noelle, Bolf, Eric, Davidson, Cole, Tomczak, Jennifer, Frietze, Seth, Carr, Frances |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552683/ http://dx.doi.org/10.1210/js.2019-SAT-571 |
Ejemplares similares
-
SAT-573 Characterization of the Gene Expression Program of a Mutant Thyroid Hormone Receptor in Anaplastic Thyroid Cancer
por: Bolf, Eric, et al.
Publicado: (2019) -
OR21-03 Determining Novel Therapeutic Targets Using an in Vitro Model of TRb Tumor Suppression in Anaplastic Thyroid Cancer
por: Gillis, Noelle E, et al.
Publicado: (2020) -
Thyroid Hormone Receptor Beta Inhibits PI3K-Akt-mTOR Signaling Axis in Anaplastic Thyroid Cancer via Genomic Mechanisms
por: Davidson, Cole D, et al.
Publicado: (2021) -
SAT571 When Two Is Too Few: Bethesda IV Pathology On Repeat Thyroid Fine Needle Aspiration
por: Godar, Cassandra M, et al.
Publicado: (2023) -
SAT566 A Rare Case Of Aggressive Anaplastic Thyroid Presenting As Thyrotoxicosis
por: Al-Juboori, Amenah, et al.
Publicado: (2023)